Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Clinical trial NCT05977907 · RECRUITING
Trial details
- NCT number
- NCT05977907
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-14
- Primary completion
- 2026-10-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.